• LAST PRICE
    6.5800
  • TODAY'S CHANGE (%)
    Trending Down-0.1536 (-2.2811%)
  • Bid / Lots
    6.3300/ 1
  • Ask / Lots
    6.6600/ 2
  • Open / Previous Close
    6.5000 / 6.7336
  • Day Range
    Low 6.5000
    High 6.6700
  • 52 Week Range
    Low 5.5000
    High 29.0600
  • Volume
    4,193
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 6.7336
TimeVolumeMOLN
09:42 ET2006.5
10:02 ET1006.57
10:09 ET3006.57
10:38 ET13006.57
11:48 ET5006.58
11:57 ET1006.67
12:17 ET1006.6599
12:24 ET4006.644
03:08 ET2006.62
03:55 ET5006.58
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMOLN
Molecular Partners AG
237.2M
1.7x
---
United StatesZOM
Zomedica Corp
252.6M
-14.4x
---
United StatesLCTX
Lineage Cell Therapeutics Inc
238.0M
-4.8x
---
United StatesRLYB
Rallybio Corp
261.1M
-3.4x
---
United StatesFENC
Fennec Pharmaceuticals Inc
248.6M
-11.6x
---
United StatesGLSI
Greenwich Lifesciences Inc
248.5M
-34.1x
---
As of 2023-01-29

Company Information

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Contact Information

Headquarters
Wagistrasse 14SCHLIEREN, Switzerland 8952
Phone
---
Fax
---

Executives

Non-Executive Independent Chairman of the Board
William Burns
Chief Executive Officer, Executive Director, Member of the Management Board
Patrick Amstutz
Chief Financial Officer, Member of the Management Board
Andreas Emmenegger
Chief Operating Officer, Member of the Management Board
Michael Stumpp
Chief Medical Officer, Member of the Management Board
Nicolas Leupin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$237.2M
Revenue (TTM)
$205.0M
Shares Outstanding
36.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$3.82
Book Value
$3.61
P/E Ratio
1.7x
Price/Sales (TTM)
1.2
Price/Cash Flow (TTM)
1.8x
Operating Margin
61.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.